Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06296797 · ClinicalTrials.gov registry record · NA
Patient-centered Information on Permanent Contraception
A NA study of Contraception and Contraception Behavior, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 650
- Enrollment target
- 1
- Study location
NCT06296797: Recruiting NA study of Contraception and Contraception Behavior, sponsored by University of California, San Francisco.
NCT06296797 is a NA study of Contraception and Contraception Behavior that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 650 participants, above the 446-participant average among 72 other Contraception trials with a reported enrollment target (46% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06296797, a NA study of Contraception and Contraception Behavior, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 650 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to understand whether providing information to women with a strong desire to avoid future pregnancy about how tubal sterilization compares to long-acting reversible contraceptives improves perceived access to available contraceptives. Participants will: * Complete a baseline survey * Receive access to web-based educational resources * Complete a brief follow up survey immediately after exploring these web-based resources * Complete a follow-up survey 3 months after enrolling The investigators will compare outcomes among participants provided with access to a new website (intervention) summarizing recent patient-centered outcomes research (PCOR) comparing interval laparoscopic tubal sterilization and long-acting reversible contraception (LARC) to control participants provided with access to the existing Planned Parenthood website on tubal sterilization.
Primary Outcome
A 9-item, multi-dimensional measure assessing awareness, availability, accessibility, affordability, and acceptability of contraceptive options including tubal sterilization, vasectomy, the subdermal implant, hormonal intrauterine device, and hormone-free intrauterine device. A summative score ranging from 0 to 48 points will be calculated for each participant at baseline and follow up. Investigators hypothesize there will be greater improvements from baseline to follow up in the intervention th
Conditions Studied
Interventions
- BEHAVIORAL Control arm: Existing educational website
- BEHAVIORAL Advancing Access Website
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2026-08-01 |
| Phase | NA |
What NCT06296797 shows while recruiting
NCT06296797 is an interventional study that assigns participants to a tested intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, above the 446-participant average among 72 other Contraception trials with a reported enrollment target (46% higher).
The record links to 3 conditions, with Contraception appearing as the primary indexed condition, and to 2 interventions - of which Control arm: Existing educational website is the first listed.
NCT06296797 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06296797 about?
NCT06296797 is a clinical study titled "Patient-centered Information on Permanent Contraception". The goal of this study is to understand whether providing information to women with a strong desire to avoid future pregnancy about how tubal sterilization compares to long-acting reversible contraceptives improves perceived access to available contraceptives. Participants will: * Complete a basel...
What is the current status of trial NCT06296797?
This trial is currently recruiting. It is a NA study. The enrollment target is 650 participants. The study started on 2024-04-01. Estimated completion is 2026-08-01.
What conditions does trial NCT06296797 study?
This clinical trial studies the following conditions: Contraception, Contraception Behavior, Reproductive Behavior.
What interventions are being tested in trial NCT06296797?
The interventions under investigation include: Control arm: Existing educational website (BEHAVIORAL), Advancing Access Website (BEHAVIORAL).
Who is sponsoring clinical trial NCT06296797?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06296797 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06296797's enrollment target sits among peer trials
650 18th of 72 higher than 55 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05046600 · 650 participants
Registry of Arthrex Hand and Wrist Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI